VaxThera, a SURA Company Created in Colombia for the Research and Development of Vaccines for Latin America
Medellin, June 29th, 2021 – Understanding Latin America’s need of self-sufficiency in order to face future pandemics, and with the preservation of life as a priority, we have created VaxThera: a SURA Company expert in the research, development and commercialization of vaccines in Colombia and the region. This company has a projected investment of 54 million […]
VaxThera to start construction of a vaccine production and Fill-and-finish plant in Colombia
September 20, 2021. VaxThera, a biotechnology company focused on research, development, and production of vaccines and other biologicals, has announced that its 35,000 m² production and bottling plant will be located in Rionegro, a municipality in the east of Antioquia. The plant will have the highest technological and human talent standards and will create over 500 […]
Construction work has begun to build the VaxThera plant, which will produce vaccines and biologicals for Colombia and the region
Rionegro, February 02, 2022 – After more than 20 years without vaccines or biologicals being produced in the country, VaxThera, a Colombian company specializing in biotechnology, began construction of its manufacturing plant in Rionegro, Antioquia. Colombia will once again be in control of its own healthcare systems. Thanks to the investment of 54 million dollars by […]
Independence of Biologicals for Colombia: Why is it historically important?
Medellín, July 2022. Within the framework of Colombian Independence Day, the country is celebrating the first anniversary of VaxThera, a Colombian company owned by Seguros SURA, that is an expert on biotechnology, and will contribute to the country’s and the region’s independence in terms of vaccines and biologicals. No vaccines have been produced in Colombia […]
Seguros SURA took second place in ANDI’s innovation ranking, highlighting VaxThera as its biggest innovation during the past year
August 16, 2022. Colombia’s National Association of Industrialists (Asociación Nacional de Empresarios – ANDI) each year recognizes the efforts, work, and results in the area of innovation in the private sector and does this through its Business Innovation Ranking. In its sixth edition, SURA took second place as the country’s most innovative company, climbing eight […]
Know the vaccines that should be applied depending on the time of life
Medellín, 27 de abril del 2023. Con los avances científicos que se han desarrollado en los últimos años se ha hecho evidente que las vacunas salvan vidas. Al respecto, la Organización Panamericana de la Salud estimaba que de cumplirse con los objetivos de cobertura para la introducción y/o la utilización continua de únicamente 10 vacunas, […]
Two women at the service of life
Medellín, March 8, 2022 – as part of the celebration of International Woman’s Day, and almost a month after the celebration of the International Day of Women and Girls in Science, we still feel the need to vindicate gender equality in professional and everyday life were recognizing women’s empowerment has been a challenge. According to the […]
World health Day: Vaccines DO Save Lives
Colombia, April 2022 – The lessons learned by society from the pandemic caused by SARS-CoV-2 is a new meaning of health, and the responsibility shared by all humans for practices that promote community well-being. This is why, to celebrate World Health Day, VaxThera, a Seguros SURA company, an expert on research, development, and innovation of vaccines […]
VaxThera and Gennova Biopharmaceuticals join efforts to strengthen their technological capabilities for developing vaccines and biologicals for Colombia and Latin America
June 10, 2022. COVID-19 has taught us that the world must be prepared for future pandemics. To protect people from emerging diseases and future pandemics, we must utilize all our human, technological, and logistical capabilities. VaxThera, a Colombian biotechnology company backed by an investment from Seguros SURA, seeks to contribute to the independence of biologics and […]
Meet the women who contribute to research and science for the development of Colombian vaccines
Women make up 51% of VaxThera’s workforce, holding leadership, research, and biological product development roles within the country.The company is set to complete the first phase of its facility construction, which will have the capacity to produce over 100 million vaccines annually and create more than 500 new, highly skilled jobs over the next five […]
